Autoimmune thyroid disease is the most common autoimmune disorder. Evidence regarding causes of the high prevalence and incidence of thyroid autoimmunity in women, and especially women of reproductive age, is still inconclusive and previous studies have suggested genetic, environmental, and existential factors to play a role in its pathogenesis. In this study, we aimed to investigate the effect of parity and other reproductive factors on the incidence of thyroid autoimmunity within the framework of the Tehran Thyroid Study (TTS).
Materials and Methods:
This study was conducted within the framework of the TTS and 1999 nonpregnant euthyroid thyroid peroxidase antibody (TPOAb) negative women were followed up for an average of 8.3 years. A pooled logistic regression model was used to assess the association (odds ratio) between time-dependent covariates parity, menopause, and abortion, and incidence of TPOAb positivity.
Results:
The total incidence rate of TPOAb positivity was 8.65 [7.35–10.18] per 1000 person-years. We found no significant association between changes in the number of parity and risk of developing TPOAb using multiple pooled logistic models both as crude effect and after adjustment for age, body mass index, and smoking. Similarly, there was no association between changes of parity, menopause, and abortion status, and incidence of TPOAb positivity.
Conclusions:
Parity does not seem to have an independent role in triggering thyroid autoimmunity, but vast immunological and physiological changes during pregnancy may act as a precipitating factor in the context of other genetic and environmental modifiers.
McLachlanSM, RapoportB. 2014. Breaking tolerance to thyroid antigens: changing concepts in thyroid autoimmunity. Endocr Rev, 35:59–105.
3.
WiersingaWM. 2016. Clinical relevance of environmental factors in the pathogenesis of autoimmune thyroid disease. Endocrinol Metab, 31:213–222.
4.
JorgensenKT, PedersenBV, NielsenNM, JacobsenS, FrischM. 2012. Childbirths and risk of female predominant and other autoimmune diseases in a population-based Danish cohort. J Autoimmun, 38:J81–J87.
5.
RochesterDB, DaviesTF. 2005. Increased risk of Graves' disease after pregnancy. Thyroid, 15:1287–1290.
6.
KitaM, GoulisD, AvramidesA. 2002. Post-partum thyroiditis in a Mediterranean population: a prospective study of a large cohort of thyroid antibody positive women at the time of delivery. J Endocrinol Invest, 25:513–519.
7.
KlintscharM, SchwaigerP, MannweilerS, RegauerS, KleiberM. 2001. Evidence of fetal microchimerism in Hashimoto's thyroiditis. J Clin Endocrinol Metab, 86:2494–2498.
8.
LepezT, VandewoestyneM, DeforceD. 2013. Fetal microchimeric cells in autoimmune thyroid diseases: harmful, beneficial or innocent for the thyroid gland?. Chimerism, 4:111–118.
9.
WangC, CrapoLM. 1997. The epidemiology of thyroid disease and implications for screening. Endocrinol Metab Clin, 26:189–218.
10.
del GhiandaS, TonaccheraM, VittiP. 2014. Thyroid and menopause. Climacteric, 17:225–234.
11.
DeGroot LJ 2017 Autoimmunity in the thyroid gland. In: Weetman A (ed). ENDOCRINE EDUCATION, Inc., South Dartmouth, MA, pp. 43–45.
12.
McLachlanSM, RapoportB. 2007. Thyroid peroxidase as an autoantigen. Thyroid, 17:939–948.
13.
YehudaM, WangCH, PakY, ChiuKC, GianoukakisAG. 2017. Parity and risk of thyroid autoimmunity based on the NHANES (2001–2002, 2007–2008, 2009–2010, and 2011–2012). J Clin Endocrinol Metab, 102:3437–3442.
14.
GreerLG, CaseyBM, HalvorsonLM, SpongCY, McIntireDD, CunninghamFG. 2011. Antithyroid antibodies and parity: further evidence for microchimerism in autoimmune thyroid disease. Am J Obstet Gynecol, 205:471.e471–e474.
15.
FriedrichN, SchwarzS, ThonackJ, JohnU, WallaschofskiH, VolzkeH. 2008. Association between parity and autoimmune thyroiditis in a general female population. Autoimmunity, 41:174–180.
16.
WalshJP, BremnerAP, BulsaraMK, O'LearyP, LeedmanPJ, FeddemaP, MichelangeliV. 2005. Parity and the risk of autoimmune thyroid disease: a community-based study. J Clin Endocrinol Metab, 90:5309–5312.
17.
SgarbiJA, KasamatsuTS, MatsumuraLK, MacielRM. 2010. Parity is not related to autoimmune thyroid disease in a population-based study of Japanese-Brazilians. Thyroid, 20:1151–1156.
18.
Bulow PedersenI, LaurbergP, KnudsenN, JorgensenT, PerrildH, OvesenL, RasmussenLB. 2006. Lack of association between thyroid autoantibodies and parity in a population study argues against microchimerism as a trigger of thyroid autoimmunity. Eur J Endocrinol, 154:39–45.
19.
BjergvedL, CarleA, JorgensenT, PerrildH, LaurbergP, KrejbjergA, OvesenL, Bulow PedersenI, RasmussenLB, KnudsenN. 2016. Parity and 11-year serum thyrotropin and thyroid autoantibody change: a longitudinal population-based study. Thyroid, 26:203–211.
20.
AmouzegarA, MehranL, TakyarM, AbdiH, AziziF. 2018. Tehran Thyroid Study (TTS). Int J Endocrinol Metab, 16:e84727.
21.
CunninghamF, LevenoK, BloomS, SpongCY, DasheJ. 2014. Williams Obstetrics. 24th edition. Mcgraw-Hill, New York.
22.
AmouzegarA, BakhtiyariM, MansourniaMA, EtemadiA, MehranL, TohidiM, AziziF. 2016. Sex- and age-specific reference values and cutoff points for TPOAb: Tehran Thyroid Study. Thyroid, 26:458–465.
23.
AmouzegarA, GharibzadehS, KazemianE, MehranL, TohidiM, AziziF. 2017. The prevalence, incidence and natural course of positive antithyroperoxidase antibodies in a population-based study: Tehran Thyroid Study. PLoS One, 12:e0169283.
24.
StriederTG, PrummelMF, TijssenJG, EndertE, WiersingaWM. 2003. Risk factors for and prevalence of thyroid disorders in a cross-sectional study among healthy female relatives of patients with autoimmune thyroid disease. Clin Endocrinol, 59:396–401.
25.
FriedrichN, RosskopfD, BrabantG, VolzkeH, NauckM, WallaschofskiH. 2010. Associations of anthropometric parameters with serum TSH, prolactin, IGF-I, and testosterone levels: results of the study of health in Pomerania (SHIP). Exp Clin Endocrinol Diabetes, 118:266–273.
26.
CarleA, PedersenIB, KnudsenN, PerrildH, OvesenL, RasmussenLB, LaurbergP. 2014. Development of autoimmune overt hypothyroidism is highly associated with live births and induced abortions but only in premenopausal women. J Clin Endocrinol Metab, 99:2241–2249.
27.
TengW, ShanZ, TengX, GuanH, LiY, TengD, JinY, YuX, FanC, ChongW. 2006. Effect of iodine intake on thyroid diseases in China. N Engl J Med, 354:2783–2793.
28.
ZoisC, StavrouI, SvarnaE, SeferiadisK, TsatsoulisA. 2006. Natural course of autoimmune thyroiditis after elimination of iodine deficiency in northwestern Greece. Thyroid, 16:289–293.
29.
Bülow PedersenI, LaurbergP, KnudsenN, JørgensenT, PerrildH, OvesenL, RasmussenLB. 2007. An increased incidence of overt hypothyroidism after iodine fortification of salt in Denmark: a prospective population study. J Clin Endocrinol Metab, 92:3122–3127.
30.
PedersenIB, KnudsenN, JørgensenT, PerrildH, OvesenL, LaurbergP. 2003. Thyroid peroxidase and thyroglobulin autoantibodies in a large survey of populations with mild and moderate iodine deficiency. Clin Endocrinol, 58:36–42.
31.
PremawardhanaL, ParkesA, AmmariF, JohnR, DarkeC, AdamsH, LazarusJ. 2000. Postpartum thyroiditis and long-term thyroid status: prognostic influence of thyroid peroxidase antibodies and ultrasound echogenicity. J Clin Endocrinol Metab, 85:71–75.
32.
EffraimidisG, WiersingaWM. 2014. Mechanisms in endocrinology: autoimmune thyroid disease: old and new players. Eur J Endocrinol, 170:R241–R252.
33.
TomerY. 2014. Mechanisms of autoimmune thyroid diseases: from genetics to epigenetics. Annu Rev Pathol, 9:147–156.
GaberscekS, ZaletelK. 2011. Thyroid physiology and autoimmunity in pregnancy and after delivery. Expert Rev Clin Immunol, 7:697–706; quiz 707.
36.
Stagnaro-GreenA. 2004. Postpartum thyroiditis. Best Pract Res Clin Endocrinol Metab, 18:303–316.
37.
RotondiM, PiraliB, LodigianiS, BrayS, LeporatiP, ChytirisS, BalzanoS, MagriF, ChiovatoL. 2008. The post partum period and the onset of Graves' disease: an overestimated risk factor. Eur J Endocrinol, 159:161–165.
38.
AndersenSL, CarleA, OlsenJ, LaurbergP. 2016. Hypothyroidism incidence in and around pregnancy: a Danish nationwide study. Eur J Endocrinol, 175:387–393.
